General Info

Jeffrey Holzbeierlein, MD, FACS, specializes in the treatment of genitourinary malignancies, including bladder, kidney, testicular and penile cancers. He is the William L. Valk Endowed Professor and chair of urology for The University of Kansas Health System. He was raised in Edmond, Oklahoma, and received his undergraduate degree from Vanderbilt University and medical degree from the University of Oklahoma. He joined the faculty at the University of Kansas Medical Center after completing his internship and residency at Vanderbilt University and a fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center in New York. Dr. Holzbeierlein is on the executive board of directors and is a past-president of the south central sect